NCT00213746View on ClinicalTrials.gov

Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

December 31, 2005

Conditions
Coronary ArteriosclerosisHeart Failure, CongestiveMyocardial InfarctionMyocardial IschemiaMyocardial Stunning
Trial Locations (8)

14000

University Hospital of Caen, Caen

29200

CHU de Brest, Brest

54037

University Hospital of Nancy, Nancy

75908

Hopital Européen Georges Pompidou, Paris

76031

University Hospital of Rouen, Rouen

91100

Hopital Sud-Francilien, Corbeil

93009

Hopital Avicenne, Bobigny

B 1090

AZ-VUB, Brussels

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

GE Healthcare

INDUSTRY

collaborator

Fédération Française de Cardiologie

OTHER

collaborator

Société Française de Cardiologie

OTHER

collaborator

Société Française de Médecine Nucléaire

UNKNOWN

lead

University Hospital, Rouen

OTHER